The effect of Atorvastatin and rosuvastatin on the Levels of 25 Hydroxyvitamin D

Comparison of the effect of Atorvastatin and rosuvastatin Treatment on the Levels of 25 Hydroxyvitamin D in patient with acute coronary syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190902044673N1

Enrollment

Registered

2019-11-07

Start date

2016-09-22

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with Acute Coronary Syndrome. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: The first group of intervention: These patients were randomly subjected to either a single dose of 80 mg Atorvastatin as a secondary prevention treatment plus a routine treatment regi

moreover, 10 ml fasting blood samples were collected within the first 24 h and 2 months after the patients were admitted to the hospital. In addition, blood samples were analyzed for biochemical param

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Acute Coronary Syndrome with: chest pain, ECG ST elevation and Troponin Enzyme rising

Exclusion criteria

Exclusion criteria: Diabetes Mellitus Take anti-lipid drugs during three past months

Design outcomes

Primary

Measure	Time frame
25-hydroxy vitamin D level. Timepoint: At the beginning ,the first 24 hours of hospitalization, two months after admission. Method of measurement: 25-hydroxy vitamin D level in blood.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamaneh Tabaei

Neyshabour University of Medical Sciences

tabaees79@yahoo.com+98 51 4263 2470

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026